Section one: Contracting authority
one.1) Name and addresses
Regional Business Services Organisation, Procurement and Logistics Service
77 Boucher Crescent
Belfast
BT126HU
Country
United Kingdom
Region code
UKN - Northern Ireland
Justification for not providing organisation identifier
Not on any register
Internet address(es)
Main address
http://etendersni.gov.uk/epps/home/do
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Seasonal Influenza Vaccines 2025/2026
Reference number
5551307
two.1.2) Main CPV code
- 33600000 - Pharmaceutical products
two.1.3) Type of contract
Supplies
two.1.4) Short description
This contract is for the procurement of a range of Seasonal Influenza Vaccines for the population of Northern Ireland
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £5,166,140
two.2) Description
two.2.3) Place of performance
NUTS codes
- UKN - Northern Ireland
two.2.4) Description of the procurement
Contract 5551307 is established under the Medicinal Products Dynamic Purchasing System (131864). This contract is for a range of Seasonal Influenza vaccines for the population of Northern Ireland.
two.2.5) Award criteria
Quality criterion - Name: All Categories (A, B, C, D): Compliance with Contract Scope and Specification / Weighting: Pass/Fail
Quality criterion - Name: All Categories (A, B, C, D): Registration on the NHS Evergreen Sustainable Supplier Assessment platform / Weighting: Pass/Fail
Quality criterion - Name: All Categories (A, B, C, D): Supply and Delivery of Product (GDP Compliance) / Weighting: Pass/Fail
Quality criterion - Name: All Categories (A, B, C, D): Governance, Quality Control and Risk (PQA Section 1) / Weighting: Pass/Fail
Quality criterion - Name: All Categories (A, B, C, D): Governance, Quality Control and Risk (PQA Section 2-6) / Weighting: 10%
Quality criterion - Name: Categories A & B only: Governance, Quality Control and Risk (Safety Engineered Protective Needle) / Weighting: 10%
Quality criterion - Name: Categories C & D only: Governance, Quality Control and Risk (Safety Engineered Protective Needle) / Weighting: 4%
Quality criterion - Name: Categories A & B only: Product Makeup (Ovalbumin Content) / Weighting: 10%
Quality criterion - Name: All Categories (A, B, C, D): Product Makeup (Formaldehyde Content) / Weighting: 1%
Quality criterion - Name: All Categories (A, B, C, D): Product Makeup (Latex Status/Threat) / Weighting: 1%
Quality criterion - Name: All Categories (A, B, C, D): Supporting Information (Availability of PILs) / Weighting: 3%
Quality criterion - Name: All Categories (A, B, C, D): Supply and Delivery of Product (Delivery Timescales) / Weighting: 25%
Quality criterion - Name: Categories C & D only: Product Licence (Age Group Coverage) / Weighting: 16%
Price - Weighting: 40%
two.2.11) Information about options
Options: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Restricted procedure
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.1) Previous publication concerning this procedure
Notice number: 2015/S 243-440518
Section five. Award of contract
Contract No
5551307
Title
Seasonal Influenza Vaccines 2025/26
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
2 April 2025
five.2.2) Information about tenders
Number of tenders received: 2
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Seqirus UK Ltd
Seqirus UK Ltd
Maidenhead
SL68AA
Country
United Kingdom
NUTS code
- UK - United Kingdom
Justification for not providing organisation identifier
Not on any register
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Total value of the contract/lot: £5,166,140
Section six. Complementary information
six.3) Additional information
The figure in V.2.4 is the awarded figure based on volume of doses agreed at the time of tender award. However, should there be a requirement for additional volumes, the Authority reserves the right to purchase further volumes up to a combined overall maximum value of £7862500 which accounts for the tendered cost associated with the maximum volume of doses set out in the tender documentation. Should additional product be required under this contract, the maximum value of combined purchases shall not exceed £7862500.
six.4) Procedures for review
six.4.1) Review body
Business Services Organisation, PaLS
Belfast
Country
United Kingdom